Dr Shalini Bajaj

About

I am a Medicinal Chemist, done my PhD in Pharmaceutical Chemistry from Guru Ghasidas Vishwavidyalaya (A Central University) Bilaspur (C.G.). Currently I am working as a Woman Scientist in SPPSPTM NMIMS Mumbai. I was awarded with Women Scientist A (WOS-A) project grant from Department of Science & Technology (DST) New Delhi of 25 Lakh rupees to work on cancer.
My area of Research is drug designing by computational molecular modeling software, synthesis of novel derivatives of 1,3,4‐oxadiazole and evaluation of its role in cancer treatment with targeting Telomerase and Thymidine Phosphorylase enzyme.

Employment

Employment history is unavailable.

Education

• Guru Ghasidas Vishwavidyalaya PhD
  2013 - Present

Projects & Funding

Projects & funding information is unavailable.

Publications (12)

• Exploring Rheumatoid Arthritis: Unraveling Signaling Pathways, Advancing Management, and Charting Future Perspectives
  Shalini Bajaj, Sunny Rathee, Umesh Kumar Patil
  Current Bioactive Compounds 2025 DOI: 10.2174/0115734072317179240919081449
  +Save
• Design, synthesis, modelling studies and biological evaluation of 1,3,4-oxadiazole derivatives as potent anticancer agents targeting thymidine phosphorylase enzyme
  Shalini Bajaj, Maushmi Shailesh Kumar, Hussain Tinwala +1 more
  Bioorganic Chemistry 2021 DOI: 10.1016/j.bioorg.2021.104873
  +Save
• Targeting telomerase for its advent in cancer therapeutics
  Shalini Bajaj, Maushmi Shailesh Kumar, Godefridus J. Peters +1 more
  Medicinal Research Reviews 2020 DOI: 10.1002/med.21674
  +Save
• 3D-QSAR and Molecular Docking Studies on Oxadiazole Substituted Benzimidazole Derivatives: Validation of Experimental Inhibitory Potencies Towards COX-2
  Vivek Asati, Piyush Ghode, Shalini Bajaj +2 more
  Current Computer-Aided Drug Design 2019 DOI: 10.2174/1573409914666181003153249
  +Save
• An overview of tramadol and its usage in pain management and future perspective
  Muna Subedi, Shalini Bajaj, Maushmi Shailesh Kumar +1 more
  Biomedicine & Pharmacotherapy 2019 DOI: 10.1016/j.biopha.2018.12.085
  +Save
• Design Potent Telomerase Inhibitors Using Structure Based Approaches
  Special Publications 2019 DOI: 10.1039/9781839160783-00060
  +Save
• Synthesis, thymidine phosphorylase inhibitory and computational study of novel 1,3,4-oxadiazole-2-thione derivatives as potential anticancer agents
  Shalini Bajaj, Partha Pratim Roy, Jagadish Singh
  Computational Biology and Chemistry 2018 DOI: 10.1016/j.compbiolchem.2018.05.013
  +Save
• Quantitative Structure–Activity Relationship and Combinatorial Design of 1,3,4-Oxadiazole-Based Thymidine Phosphorylase Inhibitors as Potential Anti-Cancer Agents
  Shalini Bajaj, Piyush Ghode, Jagadish Singh +2 more
  Current Science 2018 DOI: 10.18520/cs/v114/i10/2063-2071
  +Save
• 1,3,4-Oxadiazoles as Telomerase Inhibitor: Potential Anticancer Agents
  Shalini Bajaj, Partha Pratim Roy, Jagadish Singh
  Anti-Cancer Agents in Medicinal Chemistry 2018 DOI: 10.2174/1871521409666170425092906
  +Save
• Synthesis and Evaluation of Anticancer Activity of 1, 3, 4-Oxadiazole Derivatives against Ehrlich Ascites Carcinoma Bearing Mice and Their Correlation with Histopathology of Liver
  Partha Pratim Roy, Shalini Bajaj, Tapan Kumar Maity +1 more
  Indian Journal of Pharmaceutical Education and Research 2017 DOI: 10.5530/ijper.51.2.31
  +Save
• Molecular modeling studies of some thiazolidine-2,4-dione derivatives as 15-PGDH inhibitors
  Vivek Asati, Shalini Bajaj, Debarshi Kar Mahapatra +1 more
  Medicinal Chemistry Research 2016 DOI: 10.1007/s00044-015-1442-5
  +Save
• 1,3,4-Oxadiazoles: An emerging scaffold to target growth factors, enzymes and kinases as anticancer agents
  Shalini Bajaj, Vivek Asati, Jagadish Singh +1 more
  European Journal of Medicinal Chemistry 2015 DOI: 10.1016/j.ejmech.2015.04.051
  +Save